Development of a Novel Anti−CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas

CD44 is a cell surface glycoprotein, which is expressed on normal cells, and overexpressed on cancer cells. CD44 is involved in cell adhesion, migration, proliferation, survival, stemness, and chemo−resistance. Therefore, CD44 is thought to be a promising target for cancer diagnosis and therapy. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Nohara, Suzuki, Hiroyuki, Tanaka, Tomohiro, Asano, Teizo, Kaneko, Mika K., Kato, Yukinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146722/
https://www.ncbi.nlm.nih.gov/pubmed/35628345
http://dx.doi.org/10.3390/ijms23105535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146722/
https://www.ncbi.nlm.nih.gov/pubmed/35628345
http://dx.doi.org/10.3390/ijms23105535

Ejemplares similares